Irritable Bowel Syndrome: Contemporary Management Approaches, Limitations, and Future Directions

Area of Science:

• Gastroenterology and Gut-Brain Interaction Research
• Clinical Management of Functional Gastrointestinal Disorders

Background:

• Irritable bowel syndrome (IBS) is a prevalent gut-brain disorder causing abdominal pain and altered bowel habits.
• Its complex pathophysiology, involving motility, hypersensitivity, and signaling, complicates effective management.
• IBS significantly impacts quality of life and healthcare utilization.

Purpose of the Study:

• To review contemporary management strategies for IBS.
• To highlight evidence-based interventions including dietary, psychological, and pharmacologic treatments.
• To discuss emerging approaches like biomarker-guided and digital health strategies.

Main Methods:

• Narrative review of current literature on IBS management.
• Focus on dietary interventions (e.g., low FODMAP diet, soluble fiber).
• Evaluation of psychological therapies (e.g., CBT, hypnotherapy) and pharmacologic agents.
• Consideration of digital therapeutics and integrated care models.

Main Results:

• Multiple treatment domains show meaningful benefits for IBS symptoms.
• Dietary interventions like the low FODMAP diet and soluble fiber are effective.
• Psychological therapies and subtype-specific medications offer significant improvements.
• Digital therapeutics enhance access to behavioral support and self-management.

Conclusions:

• IBS management requires a multifactorial and personalized approach.
• Precision-oriented strategies integrating phenotyping and biomarkers are crucial for future progress.
• Further research on long-term treatment sequencing and mechanism-based care is essential.
• Improving IBS outcomes necessitates pragmatic trials and real-world implementation.